StockData
Pelthos Therapeutics Inc. logo

Pelthos Therapeutics Inc. (PTHS) stock

PTHSNYSEBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 2/30
$7.10+0.26 (+3.80%)

Close on Nov 18, 2026Market cap $27.18MP/E –Yield –

Pelthos Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Pelthos Therapeutics's market cap was $34.92M on Nov 11, 2026, against $87.78M a year earlier. Over the last 3 years it ranged from $3.55M to $96.58M, with a median of $14.73M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$34.92M-63.6%
2025Dec 31, 2025$95.81M+2469.1%
2024Dec 31, 2024$3.73M–

More Pelthos Therapeutics figures

See a number that looks wrong?